发明名称 USE OF D4 AND 5-HT2A ANTAGONIST, INVERSE AGONIST OR PARTIAL AGONIST
摘要 PROBLEM TO BE SOLVED: To enable the treatment of the dysregulation of emotional functionality, underlying mental disorder (e.g. instability, hypersensitivity, hyperesthesia, dissociative phenomenon). SOLUTION: A medicinal composition contains (i) a compound having a D4-antagonistic, partial agonistic or inverse agonistic activities, (ii) a compound having a D5-antagonistic, partial agonistic or inverse agonistic activities and (iii) a publicly known medicinal compound and a composition of the compounds. This composition is administered to a patient diagnosed as having mental disorder. COPYRIGHT: (C)2005,JPO&NCIPI
申请公布号 JP2005194263(A) 申请公布日期 2005.07.21
申请号 JP20040349085 申请日期 2004.11.04
申请人 B & B BEHEER 发明人 BUNTINX ERIK
分类号 A61K45/00;A61K31/00;A61K31/343;A61K31/4545;A61P25/00;A61P25/04;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P43/00;G01N33/48;(IPC1-7):A61K31/454 主分类号 A61K45/00
代理机构 代理人
主权项
地址